14,436,707 16,569,366
Total liabilities and shareholders'
equity $23,563,641 $26,473,211
DATATRAK International, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
For the Three Months
Ended March 31,
2008 2007
Revenue $2,088,229 $3,542,095
Direct costs 933,879 1,337,471
Gross profit 1,154,350 2,204,624
Selling, general and administrative
expenses 2,856,600 3,422,671
Depreciation and amortization 522,426 622,403
Loss from operations (2,224,676) (1,840,450)
Interest income 59,740 70,192
Interest expense 66,567 98,669
Loss on disposal 1,382 -
Loss before income taxes (2,232,885) (1,868,927)
Income tax expense - 26,300
Net loss $(2,232,885) $(1,895,227)
Net loss per share:
Basic:
Net loss per share $(0.16) $(0.16)
Weighted-average shares
outstanding 13,681,901 11,858,949
Diluted:
Net loss per share $(0.16) $(0.16)
Weighted-average shares
outstanding
'/>"/>
SOURCE DATATRAK International, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects2.
DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.03.
Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study4.
Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research5.
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting6.
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet7.
UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation8.
Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment9.
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility10.
Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus11.
XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis